nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoprolol—Propranolol—migraine	0.391	1	CrCtD
Metoprolol—Bevantolol—Verapamil—migraine	0.0522	0.184	CrCrCtD
Metoprolol—ADRB2—Timolol—migraine	0.0289	0.127	CbGbCtD
Metoprolol—ADRB1—Timolol—migraine	0.0284	0.125	CbGbCtD
Metoprolol—Metipranolol—Propranolol—migraine	0.0278	0.0977	CrCrCtD
Metoprolol—SLC22A2—Propranolol—migraine	0.0257	0.113	CbGbCtD
Metoprolol—ADRB2—Propranolol—migraine	0.0257	0.113	CbGbCtD
Metoprolol—ADRB1—Propranolol—migraine	0.0253	0.112	CbGbCtD
Metoprolol—Acebutolol—Propranolol—migraine	0.0237	0.0832	CrCrCtD
Metoprolol—Betaxolol—Propranolol—migraine	0.0237	0.0832	CrCrCtD
Metoprolol—Bevantolol—Propranolol—migraine	0.0237	0.0832	CrCrCtD
Metoprolol—Bisoprolol—Propranolol—migraine	0.0221	0.0776	CrCrCtD
Metoprolol—Oxprenolol—Propranolol—migraine	0.0195	0.0686	CrCrCtD
Metoprolol—Practolol—Propranolol—migraine	0.0195	0.0686	CrCrCtD
Metoprolol—Alprenolol—Propranolol—migraine	0.0195	0.0686	CrCrCtD
Metoprolol—Atenolol—Propranolol—migraine	0.0185	0.0649	CrCrCtD
Metoprolol—Esmolol—Propranolol—migraine	0.0175	0.0617	CrCrCtD
Metoprolol—Pindolol—Propranolol—migraine	0.0167	0.0588	CrCrCtD
Metoprolol—CYP2C19—Timolol—migraine	0.00952	0.042	CbGbCtD
Metoprolol—CYP2C19—Propranolol—migraine	0.00849	0.0374	CbGbCtD
Metoprolol—ABCB1—Timolol—migraine	0.00768	0.0339	CbGbCtD
Metoprolol—CYP2C19—Amitriptyline—migraine	0.00734	0.0324	CbGbCtD
Metoprolol—CYP2D6—Timolol—migraine	0.00724	0.0319	CbGbCtD
Metoprolol—ABCB1—Propranolol—migraine	0.00685	0.0302	CbGbCtD
Metoprolol—CYP2C19—Valproic Acid—migraine	0.00669	0.0295	CbGbCtD
Metoprolol—CYP2D6—Propranolol—migraine	0.00645	0.0284	CbGbCtD
Metoprolol—CYP2C19—Topiramate—migraine	0.00604	0.0266	CbGbCtD
Metoprolol—ABCB1—Amitriptyline—migraine	0.00592	0.0261	CbGbCtD
Metoprolol—CYP2C19—Verapamil—migraine	0.00583	0.0257	CbGbCtD
Metoprolol—CYP2D6—Amitriptyline—migraine	0.00558	0.0246	CbGbCtD
Metoprolol—ABCB1—Verapamil—migraine	0.0047	0.0207	CbGbCtD
Metoprolol—CYP2D6—Verapamil—migraine	0.00443	0.0195	CbGbCtD
Metoprolol—ADRB1—Endothelin Pathways—RAMP1—migraine	0.000582	0.0378	CbGpPWpGaD
Metoprolol—ADRB1—Endothelin Pathways—CALCRL—migraine	0.000582	0.0378	CbGpPWpGaD
Metoprolol—ADRB1—Monoamine GPCRs—HTR1D—migraine	0.000423	0.0275	CbGpPWpGaD
Metoprolol—ADRB2—Monoamine GPCRs—HTR1D—migraine	0.000413	0.0269	CbGpPWpGaD
Metoprolol—ADRB1—Monoamine GPCRs—HTR2B—migraine	0.000393	0.0256	CbGpPWpGaD
Metoprolol—ADRB2—Monoamine GPCRs—HTR2B—migraine	0.000384	0.025	CbGpPWpGaD
Metoprolol—ADRB1—Amine ligand-binding receptors—HTR1D—migraine	0.000355	0.0231	CbGpPWpGaD
Metoprolol—ADRB2—Amine ligand-binding receptors—HTR1D—migraine	0.000348	0.0226	CbGpPWpGaD
Metoprolol—ADRB1—Amine ligand-binding receptors—HTR2B—migraine	0.00033	0.0215	CbGpPWpGaD
Metoprolol—ADRB2—Amine ligand-binding receptors—HTR2B—migraine	0.000323	0.021	CbGpPWpGaD
Metoprolol—Pindolol—HTR1B—migraine	0.000296	0.271	CrCbGaD
Metoprolol—Alprenolol—HTR1A—migraine	0.000272	0.249	CrCbGaD
Metoprolol—ADRB1—Monoamine GPCRs—HTR1B—migraine	0.000256	0.0167	CbGpPWpGaD
Metoprolol—ADRB2—Monoamine GPCRs—HTR1B—migraine	0.00025	0.0163	CbGpPWpGaD
Metoprolol—ADRB1—Monoamine GPCRs—HTR1A—migraine	0.000246	0.016	CbGpPWpGaD
Metoprolol—ADRB2—Monoamine GPCRs—HTR1A—migraine	0.000241	0.0157	CbGpPWpGaD
Metoprolol—ADRB1—Monoamine GPCRs—HTR2C—migraine	0.000238	0.0155	CbGpPWpGaD
Metoprolol—Pindolol—HTR1A—migraine	0.000234	0.215	CrCbGaD
Metoprolol—ADRB2—Monoamine GPCRs—HTR2C—migraine	0.000233	0.0151	CbGpPWpGaD
Metoprolol—ADRB1—Endothelin Pathways—EDNRA—migraine	0.000232	0.0151	CbGpPWpGaD
Metoprolol—ADRB1—Endothelin Pathways—CALCA—migraine	0.000223	0.0145	CbGpPWpGaD
Metoprolol—ADRB1—Amine ligand-binding receptors—HTR1B—migraine	0.000215	0.014	CbGpPWpGaD
Metoprolol—ADRB2—Amine ligand-binding receptors—HTR1B—migraine	0.000211	0.0137	CbGpPWpGaD
Metoprolol—ADRB1—Monoamine GPCRs—HTR7—migraine	0.000208	0.0136	CbGpPWpGaD
Metoprolol—ADRB1—Amine ligand-binding receptors—HTR1A—migraine	0.000207	0.0135	CbGpPWpGaD
Metoprolol—ADRB2—Monoamine GPCRs—HTR7—migraine	0.000204	0.0133	CbGpPWpGaD
Metoprolol—ADRB2—Amine ligand-binding receptors—HTR1A—migraine	0.000203	0.0132	CbGpPWpGaD
Metoprolol—ADRB1—G alpha (s) signalling events—RAMP1—migraine	0.000202	0.0131	CbGpPWpGaD
Metoprolol—ADRB1—G alpha (s) signalling events—CALCRL—migraine	0.000202	0.0131	CbGpPWpGaD
Metoprolol—ADRB1—Amine ligand-binding receptors—HTR2C—migraine	0.0002	0.013	CbGpPWpGaD
Metoprolol—ADRB2—G alpha (s) signalling events—RAMP1—migraine	0.000197	0.0128	CbGpPWpGaD
Metoprolol—ADRB2—G alpha (s) signalling events—CALCRL—migraine	0.000197	0.0128	CbGpPWpGaD
Metoprolol—ADRB2—Amine ligand-binding receptors—HTR2C—migraine	0.000196	0.0127	CbGpPWpGaD
Metoprolol—ADRB1—Amine ligand-binding receptors—HTR7—migraine	0.000175	0.0114	CbGpPWpGaD
Metoprolol—ADRB2—Amine ligand-binding receptors—HTR7—migraine	0.000171	0.0112	CbGpPWpGaD
Metoprolol—Propranolol—HTR1B—migraine	0.000162	0.148	CrCbGaD
Metoprolol—SLC22A2—Neuronal System—KCNK18—migraine	0.000156	0.0101	CbGpPWpGaD
Metoprolol—ADRB1—Monoamine GPCRs—HTR2A—migraine	0.000146	0.0095	CbGpPWpGaD
Metoprolol—ADRB2—Monoamine GPCRs—HTR2A—migraine	0.000143	0.00929	CbGpPWpGaD
Metoprolol—ADRB1—Calcium Regulation in the Cardiac Cell—CACNA1A—migraine	0.000132	0.00858	CbGpPWpGaD
Metoprolol—ADRB2—Calcium Regulation in the Cardiac Cell—CACNA1A—migraine	0.000129	0.0084	CbGpPWpGaD
Metoprolol—Propranolol—HTR1A—migraine	0.000128	0.117	CrCbGaD
Metoprolol—ADRB1—Amine ligand-binding receptors—HTR2A—migraine	0.000123	0.00798	CbGpPWpGaD
Metoprolol—ADRB2—Amine ligand-binding receptors—HTR2A—migraine	0.00012	0.00781	CbGpPWpGaD
Metoprolol—ADRB2—GPCRs, Other—EDNRA—migraine	0.000101	0.00654	CbGpPWpGaD
Metoprolol—SLC22A2—Transmission across Chemical Synapses—CACNA1A—migraine	9.92e-05	0.00645	CbGpPWpGaD
Metoprolol—ADRB2—GPCRs, Other—HTR7—migraine	9.06e-05	0.00589	CbGpPWpGaD
Metoprolol—ADRB1—G alpha (s) signalling events—NPS—migraine	8.42e-05	0.00547	CbGpPWpGaD
Metoprolol—ADRB2—G alpha (s) signalling events—NPS—migraine	8.23e-05	0.00536	CbGpPWpGaD
Metoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	8.16e-05	0.0053	CbGpPWpGaD
Metoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	7.98e-05	0.00519	CbGpPWpGaD
Metoprolol—ADRB1—G alpha (s) signalling events—CALCA—migraine	7.73e-05	0.00503	CbGpPWpGaD
Metoprolol—SLC22A2—Neuronal System—CACNA1A—migraine	7.6e-05	0.00495	CbGpPWpGaD
Metoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	7.58e-05	0.00493	CbGpPWpGaD
Metoprolol—ADRB2—G alpha (s) signalling events—CALCA—migraine	7.56e-05	0.00492	CbGpPWpGaD
Metoprolol—SLC22A2—Transmembrane transport of small molecules—TRPM8—migraine	7.46e-05	0.00485	CbGpPWpGaD
Metoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	7.42e-05	0.00482	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—RAMP1—migraine	7.32e-05	0.00476	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—CALCRL—migraine	7.32e-05	0.00476	CbGpPWpGaD
Metoprolol—ADRB1—G alpha (s) signalling events—HTR7—migraine	7.23e-05	0.0047	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—RAMP1—migraine	7.16e-05	0.00466	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—CALCRL—migraine	7.16e-05	0.00466	CbGpPWpGaD
Metoprolol—ADRB2—G alpha (s) signalling events—HTR7—migraine	7.07e-05	0.0046	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	6.99e-05	0.00454	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	6.84e-05	0.00445	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	6.5e-05	0.00423	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	6.35e-05	0.00413	CbGpPWpGaD
Metoprolol—ADRB2—GPCRs, Other—HTR2A—migraine	6.35e-05	0.00413	CbGpPWpGaD
Metoprolol—SLC22A2—Transmembrane transport of small molecules—ATP1A3—migraine	5.65e-05	0.00368	CbGpPWpGaD
Metoprolol—SLC22A2—Transmembrane transport of small molecules—ATP1A2—migraine	5.65e-05	0.00368	CbGpPWpGaD
Metoprolol—Feeling abnormal—Verapamil—migraine	5.53e-05	0.000681	CcSEcCtD
Metoprolol—Hallucination—Gabapentin—migraine	5.52e-05	0.000681	CcSEcCtD
Metoprolol—Vision blurred—Valproic Acid—migraine	5.49e-05	0.000677	CcSEcCtD
Metoprolol—Oedema peripheral—Gabapentin—migraine	5.47e-05	0.000674	CcSEcCtD
Metoprolol—Connective tissue disorder—Gabapentin—migraine	5.45e-05	0.000672	CcSEcCtD
Metoprolol—Angiopathy—Timolol—migraine	5.41e-05	0.000666	CcSEcCtD
Metoprolol—Immune system disorder—Timolol—migraine	5.38e-05	0.000663	CcSEcCtD
Metoprolol—Hypersensitivity—Propranolol—migraine	5.37e-05	0.000662	CcSEcCtD
Metoprolol—Erectile dysfunction—Topiramate—migraine	5.37e-05	0.000662	CcSEcCtD
Metoprolol—Mediastinal disorder—Timolol—migraine	5.37e-05	0.000662	CcSEcCtD
Metoprolol—Visual impairment—Gabapentin—migraine	5.35e-05	0.000659	CcSEcCtD
Metoprolol—Urticaria—Verapamil—migraine	5.33e-05	0.000657	CcSEcCtD
Metoprolol—Photosensitivity reaction—Topiramate—migraine	5.32e-05	0.000656	CcSEcCtD
Metoprolol—Arrhythmia—Timolol—migraine	5.32e-05	0.000656	CcSEcCtD
Metoprolol—ADRB1—GPCR ligand binding—HTR1D—migraine	5.32e-05	0.00346	CbGpPWpGaD
Metoprolol—Nausea—Amitriptyline—migraine	5.32e-05	0.000656	CcSEcCtD
Metoprolol—Weight increased—Topiramate—migraine	5.31e-05	0.000654	CcSEcCtD
Metoprolol—Alopecia—Timolol—migraine	5.27e-05	0.000649	CcSEcCtD
Metoprolol—Vertigo—Valproic Acid—migraine	5.24e-05	0.000645	CcSEcCtD
Metoprolol—Asthenia—Propranolol—migraine	5.23e-05	0.000645	CcSEcCtD
Metoprolol—Pneumonia—Topiramate—migraine	5.23e-05	0.000645	CcSEcCtD
Metoprolol—Mental disorder—Timolol—migraine	5.22e-05	0.000644	CcSEcCtD
Metoprolol—Leukopenia—Valproic Acid—migraine	5.22e-05	0.000643	CcSEcCtD
Metoprolol—ADRB2—GPCR ligand binding—HTR1D—migraine	5.21e-05	0.00339	CbGpPWpGaD
Metoprolol—Eye disorder—Gabapentin—migraine	5.19e-05	0.000639	CcSEcCtD
Metoprolol—Depression—Topiramate—migraine	5.19e-05	0.000639	CcSEcCtD
Metoprolol—Tinnitus—Gabapentin—migraine	5.17e-05	0.000638	CcSEcCtD
Metoprolol—Cardiac disorder—Gabapentin—migraine	5.15e-05	0.000635	CcSEcCtD
Metoprolol—Palpitations—Valproic Acid—migraine	5.15e-05	0.000635	CcSEcCtD
Metoprolol—Tension—Timolol—migraine	5.09e-05	0.000627	CcSEcCtD
Metoprolol—Dysgeusia—Timolol—migraine	5.08e-05	0.000626	CcSEcCtD
Metoprolol—Conjunctivitis—Topiramate—migraine	5.06e-05	0.000623	CcSEcCtD
Metoprolol—Nervousness—Timolol—migraine	5.04e-05	0.000621	CcSEcCtD
Metoprolol—Hypertension—Valproic Acid—migraine	5.03e-05	0.00062	CcSEcCtD
Metoprolol—Immune system disorder—Gabapentin—migraine	5.01e-05	0.000618	CcSEcCtD
Metoprolol—Mediastinal disorder—Gabapentin—migraine	5e-05	0.000616	CcSEcCtD
Metoprolol—Diarrhoea—Propranolol—migraine	4.99e-05	0.000615	CcSEcCtD
Metoprolol—Arthralgia—Valproic Acid—migraine	4.96e-05	0.000611	CcSEcCtD
Metoprolol—Chest pain—Valproic Acid—migraine	4.96e-05	0.000611	CcSEcCtD
Metoprolol—ADRB1—GPCR ligand binding—HTR2B—migraine	4.95e-05	0.00322	CbGpPWpGaD
Metoprolol—Anxiety—Valproic Acid—migraine	4.94e-05	0.000609	CcSEcCtD
Metoprolol—Hypersensitivity—Verapamil—migraine	4.94e-05	0.000609	CcSEcCtD
Metoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	4.94e-05	0.00321	CbGpPWpGaD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	4.93e-05	0.000607	CcSEcCtD
Metoprolol—Alopecia—Gabapentin—migraine	4.9e-05	0.000604	CcSEcCtD
Metoprolol—Vision blurred—Timolol—migraine	4.89e-05	0.000603	CcSEcCtD
Metoprolol—Mental disorder—Gabapentin—migraine	4.86e-05	0.000599	CcSEcCtD
Metoprolol—Agranulocytosis—Topiramate—migraine	4.85e-05	0.000598	CcSEcCtD
Metoprolol—Dry mouth—Valproic Acid—migraine	4.85e-05	0.000598	CcSEcCtD
Metoprolol—ADRB2—GPCR ligand binding—HTR2B—migraine	4.84e-05	0.00315	CbGpPWpGaD
Metoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	4.83e-05	0.00314	CbGpPWpGaD
Metoprolol—Dizziness—Propranolol—migraine	4.82e-05	0.000594	CcSEcCtD
Metoprolol—Asthenia—Verapamil—migraine	4.81e-05	0.000593	CcSEcCtD
Metoprolol—SLC22A2—Transmembrane transport of small molecules—HTR3A—migraine	4.81e-05	0.00313	CbGpPWpGaD
Metoprolol—Confusional state—Valproic Acid—migraine	4.8e-05	0.000591	CcSEcCtD
Metoprolol—Flatulence—Gabapentin—migraine	4.76e-05	0.000587	CcSEcCtD
Metoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	4.76e-05	0.00309	CbGpPWpGaD
Metoprolol—Oedema—Valproic Acid—migraine	4.76e-05	0.000586	CcSEcCtD
Metoprolol—Bradycardia—Topiramate—migraine	4.75e-05	0.000586	CcSEcCtD
Metoprolol—Pruritus—Verapamil—migraine	4.75e-05	0.000585	CcSEcCtD
Metoprolol—Tension—Gabapentin—migraine	4.74e-05	0.000584	CcSEcCtD
Metoprolol—Dysgeusia—Gabapentin—migraine	4.73e-05	0.000583	CcSEcCtD
Metoprolol—Nervousness—Gabapentin—migraine	4.69e-05	0.000578	CcSEcCtD
Metoprolol—Rhinitis—Topiramate—migraine	4.68e-05	0.000577	CcSEcCtD
Metoprolol—Hepatitis—Topiramate—migraine	4.67e-05	0.000575	CcSEcCtD
Metoprolol—Nervous system disorder—Valproic Acid—migraine	4.66e-05	0.000575	CcSEcCtD
Metoprolol—Vertigo—Timolol—migraine	4.66e-05	0.000574	CcSEcCtD
Metoprolol—Thrombocytopenia—Valproic Acid—migraine	4.66e-05	0.000574	CcSEcCtD
Metoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	4.65e-05	0.00303	CbGpPWpGaD
Metoprolol—Syncope—Timolol—migraine	4.65e-05	0.000573	CcSEcCtD
Metoprolol—Hallucination—Topiramate—migraine	4.65e-05	0.000573	CcSEcCtD
Metoprolol—Muscle spasms—Gabapentin—migraine	4.64e-05	0.000572	CcSEcCtD
Metoprolol—Tachycardia—Valproic Acid—migraine	4.64e-05	0.000572	CcSEcCtD
Metoprolol—Vomiting—Propranolol—migraine	4.64e-05	0.000571	CcSEcCtD
Metoprolol—Skin disorder—Valproic Acid—migraine	4.62e-05	0.000569	CcSEcCtD
Metoprolol—Oedema peripheral—Topiramate—migraine	4.6e-05	0.000567	CcSEcCtD
Metoprolol—Hyperhidrosis—Valproic Acid—migraine	4.6e-05	0.000567	CcSEcCtD
Metoprolol—Rash—Propranolol—migraine	4.6e-05	0.000567	CcSEcCtD
Metoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	4.59e-05	0.00299	CbGpPWpGaD
Metoprolol—Dermatitis—Propranolol—migraine	4.59e-05	0.000566	CcSEcCtD
Metoprolol—Diarrhoea—Verapamil—migraine	4.59e-05	0.000566	CcSEcCtD
Metoprolol—Connective tissue disorder—Topiramate—migraine	4.59e-05	0.000565	CcSEcCtD
Metoprolol—Palpitations—Timolol—migraine	4.58e-05	0.000565	CcSEcCtD
Metoprolol—Loss of consciousness—Timolol—migraine	4.56e-05	0.000562	CcSEcCtD
Metoprolol—Vision blurred—Gabapentin—migraine	4.55e-05	0.000561	CcSEcCtD
Metoprolol—Visual impairment—Topiramate—migraine	4.5e-05	0.000555	CcSEcCtD
Metoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	4.49e-05	0.00292	CbGpPWpGaD
Metoprolol—Hypertension—Timolol—migraine	4.48e-05	0.000552	CcSEcCtD
Metoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	4.47e-05	0.00291	CbGpPWpGaD
Metoprolol—Hypotension—Valproic Acid—migraine	4.44e-05	0.000548	CcSEcCtD
Metoprolol—Dizziness—Verapamil—migraine	4.44e-05	0.000547	CcSEcCtD
Metoprolol—Arthralgia—Timolol—migraine	4.42e-05	0.000544	CcSEcCtD
Metoprolol—Chest pain—Timolol—migraine	4.42e-05	0.000544	CcSEcCtD
Metoprolol—Anxiety—Timolol—migraine	4.4e-05	0.000542	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	4.39e-05	0.000541	CcSEcCtD
Metoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	4.37e-05	0.00284	CbGpPWpGaD
Metoprolol—Eye disorder—Topiramate—migraine	4.36e-05	0.000538	CcSEcCtD
Metoprolol—Tinnitus—Topiramate—migraine	4.35e-05	0.000537	CcSEcCtD
Metoprolol—Vertigo—Gabapentin—migraine	4.34e-05	0.000535	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Valproic Acid—migraine	4.33e-05	0.000534	CcSEcCtD
Metoprolol—Cardiac disorder—Topiramate—migraine	4.33e-05	0.000534	CcSEcCtD
Metoprolol—Syncope—Gabapentin—migraine	4.33e-05	0.000534	CcSEcCtD
Metoprolol—Nausea—Propranolol—migraine	4.33e-05	0.000534	CcSEcCtD
Metoprolol—Leukopenia—Gabapentin—migraine	4.32e-05	0.000533	CcSEcCtD
Metoprolol—Dry mouth—Timolol—migraine	4.32e-05	0.000532	CcSEcCtD
Metoprolol—Insomnia—Valproic Acid—migraine	4.3e-05	0.00053	CcSEcCtD
Metoprolol—Paraesthesia—Valproic Acid—migraine	4.27e-05	0.000526	CcSEcCtD
Metoprolol—Palpitations—Gabapentin—migraine	4.27e-05	0.000526	CcSEcCtD
Metoprolol—Confusional state—Timolol—migraine	4.27e-05	0.000526	CcSEcCtD
Metoprolol—Vomiting—Verapamil—migraine	4.27e-05	0.000526	CcSEcCtD
Metoprolol—Loss of consciousness—Gabapentin—migraine	4.25e-05	0.000523	CcSEcCtD
Metoprolol—Dyspnoea—Valproic Acid—migraine	4.24e-05	0.000523	CcSEcCtD
Metoprolol—Angiopathy—Topiramate—migraine	4.24e-05	0.000522	CcSEcCtD
Metoprolol—Oedema—Timolol—migraine	4.23e-05	0.000522	CcSEcCtD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	4.23e-05	0.00275	CbGpPWpGaD
Metoprolol—Rash—Verapamil—migraine	4.23e-05	0.000521	CcSEcCtD
Metoprolol—Somnolence—Valproic Acid—migraine	4.23e-05	0.000521	CcSEcCtD
Metoprolol—Dermatitis—Verapamil—migraine	4.23e-05	0.000521	CcSEcCtD
Metoprolol—Immune system disorder—Topiramate—migraine	4.22e-05	0.00052	CcSEcCtD
Metoprolol—Mediastinal disorder—Topiramate—migraine	4.21e-05	0.000519	CcSEcCtD
Metoprolol—Headache—Verapamil—migraine	4.2e-05	0.000518	CcSEcCtD
Metoprolol—Dyspepsia—Valproic Acid—migraine	4.19e-05	0.000516	CcSEcCtD
Metoprolol—Hypertension—Gabapentin—migraine	4.17e-05	0.000514	CcSEcCtD
Metoprolol—Shock—Timolol—migraine	4.17e-05	0.000513	CcSEcCtD
Metoprolol—Nervous system disorder—Timolol—migraine	4.15e-05	0.000512	CcSEcCtD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	4.14e-05	0.00269	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—CALCRL—migraine	4.14e-05	0.00269	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—RAMP1—migraine	4.14e-05	0.00269	CbGpPWpGaD
Metoprolol—Alopecia—Topiramate—migraine	4.13e-05	0.000509	CcSEcCtD
Metoprolol—Arthralgia—Gabapentin—migraine	4.11e-05	0.000507	CcSEcCtD
Metoprolol—Chest pain—Gabapentin—migraine	4.11e-05	0.000507	CcSEcCtD
Metoprolol—Skin disorder—Timolol—migraine	4.11e-05	0.000507	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Valproic Acid—migraine	4.11e-05	0.000506	CcSEcCtD
Metoprolol—Fatigue—Valproic Acid—migraine	4.1e-05	0.000505	CcSEcCtD
Metoprolol—Anxiety—Gabapentin—migraine	4.1e-05	0.000505	CcSEcCtD
Metoprolol—Hyperhidrosis—Timolol—migraine	4.09e-05	0.000504	CcSEcCtD
Metoprolol—Mental disorder—Topiramate—migraine	4.09e-05	0.000504	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	4.08e-05	0.000503	CcSEcCtD
Metoprolol—ABCB1—Transmembrane transport of small molecules—TRPM8—migraine	4.08e-05	0.00265	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	4.08e-05	0.00265	CbGpPWpGaD
Metoprolol—Constipation—Valproic Acid—migraine	4.07e-05	0.000501	CcSEcCtD
Metoprolol—Pain—Valproic Acid—migraine	4.07e-05	0.000501	CcSEcCtD
Metoprolol—ADRB2—GPCR downstream signaling—CALCRL—migraine	4.05e-05	0.00263	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—RAMP1—migraine	4.05e-05	0.00263	CbGpPWpGaD
Metoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	4.02e-05	0.00262	CbGpPWpGaD
Metoprolol—Dry mouth—Gabapentin—migraine	4.02e-05	0.000496	CcSEcCtD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	4.01e-05	0.00261	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	4.01e-05	0.00261	CbGpPWpGaD
Metoprolol—Flatulence—Topiramate—migraine	4.01e-05	0.000494	CcSEcCtD
Metoprolol—Tension—Topiramate—migraine	3.99e-05	0.000492	CcSEcCtD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	3.99e-05	0.00259	CbGpPWpGaD
Metoprolol—Nausea—Verapamil—migraine	3.98e-05	0.000491	CcSEcCtD
Metoprolol—Dysgeusia—Topiramate—migraine	3.98e-05	0.000491	CcSEcCtD
Metoprolol—Confusional state—Gabapentin—migraine	3.98e-05	0.00049	CcSEcCtD
Metoprolol—Hypotension—Timolol—migraine	3.96e-05	0.000488	CcSEcCtD
Metoprolol—Nervousness—Topiramate—migraine	3.95e-05	0.000487	CcSEcCtD
Metoprolol—Oedema—Gabapentin—migraine	3.94e-05	0.000486	CcSEcCtD
Metoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR7—migraine	3.94e-05	0.00256	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	3.94e-05	0.00256	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	3.93e-05	0.00255	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	3.93e-05	0.00255	CbGpPWpGaD
Metoprolol—Feeling abnormal—Valproic Acid—migraine	3.92e-05	0.000483	CcSEcCtD
Metoprolol—Muscle spasms—Topiramate—migraine	3.91e-05	0.000482	CcSEcCtD
Metoprolol—Gastrointestinal pain—Valproic Acid—migraine	3.89e-05	0.000479	CcSEcCtD
Metoprolol—Shock—Gabapentin—migraine	3.88e-05	0.000478	CcSEcCtD
Metoprolol—Nervous system disorder—Gabapentin—migraine	3.87e-05	0.000477	CcSEcCtD
Metoprolol—Thrombocytopenia—Gabapentin—migraine	3.86e-05	0.000476	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Timolol—migraine	3.86e-05	0.000475	CcSEcCtD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	3.85e-05	0.0025	CbGpPWpGaD
Metoprolol—Tachycardia—Gabapentin—migraine	3.85e-05	0.000474	CcSEcCtD
Metoprolol—Vision blurred—Topiramate—migraine	3.83e-05	0.000472	CcSEcCtD
Metoprolol—Skin disorder—Gabapentin—migraine	3.83e-05	0.000472	CcSEcCtD
Metoprolol—Insomnia—Timolol—migraine	3.83e-05	0.000472	CcSEcCtD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	3.83e-05	0.00249	CbGpPWpGaD
Metoprolol—Hyperhidrosis—Gabapentin—migraine	3.81e-05	0.00047	CcSEcCtD
Metoprolol—Paraesthesia—Timolol—migraine	3.8e-05	0.000469	CcSEcCtD
Metoprolol—Urticaria—Valproic Acid—migraine	3.78e-05	0.000466	CcSEcCtD
Metoprolol—Dyspnoea—Timolol—migraine	3.77e-05	0.000465	CcSEcCtD
Metoprolol—Somnolence—Timolol—migraine	3.76e-05	0.000464	CcSEcCtD
Metoprolol—Abdominal pain—Valproic Acid—migraine	3.76e-05	0.000463	CcSEcCtD
Metoprolol—Body temperature increased—Valproic Acid—migraine	3.76e-05	0.000463	CcSEcCtD
Metoprolol—ADRB1—Signaling by GPCR—CALCRL—migraine	3.76e-05	0.00244	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—RAMP1—migraine	3.76e-05	0.00244	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	3.75e-05	0.00244	CbGpPWpGaD
Metoprolol—Dyspepsia—Timolol—migraine	3.73e-05	0.000459	CcSEcCtD
Metoprolol—Hypotension—Gabapentin—migraine	3.68e-05	0.000454	CcSEcCtD
Metoprolol—ADRB2—Signaling by GPCR—RAMP1—migraine	3.68e-05	0.00239	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—CALCRL—migraine	3.68e-05	0.00239	CbGpPWpGaD
Metoprolol—Gastrointestinal disorder—Timolol—migraine	3.66e-05	0.000451	CcSEcCtD
Metoprolol—Vertigo—Topiramate—migraine	3.65e-05	0.00045	CcSEcCtD
Metoprolol—Fatigue—Timolol—migraine	3.65e-05	0.00045	CcSEcCtD
Metoprolol—Syncope—Topiramate—migraine	3.64e-05	0.000449	CcSEcCtD
Metoprolol—Leukopenia—Topiramate—migraine	3.64e-05	0.000448	CcSEcCtD
Metoprolol—Pain—Timolol—migraine	3.62e-05	0.000446	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Gabapentin—migraine	3.59e-05	0.000443	CcSEcCtD
Metoprolol—Palpitations—Topiramate—migraine	3.59e-05	0.000443	CcSEcCtD
Metoprolol—Loss of consciousness—Topiramate—migraine	3.57e-05	0.00044	CcSEcCtD
Metoprolol—Insomnia—Gabapentin—migraine	3.57e-05	0.00044	CcSEcCtD
Metoprolol—Paraesthesia—Gabapentin—migraine	3.54e-05	0.000436	CcSEcCtD
Metoprolol—Dyspnoea—Gabapentin—migraine	3.52e-05	0.000433	CcSEcCtD
Metoprolol—Hypertension—Topiramate—migraine	3.51e-05	0.000432	CcSEcCtD
Metoprolol—Somnolence—Gabapentin—migraine	3.51e-05	0.000432	CcSEcCtD
Metoprolol—Hypersensitivity—Valproic Acid—migraine	3.5e-05	0.000432	CcSEcCtD
Metoprolol—Feeling abnormal—Timolol—migraine	3.49e-05	0.00043	CcSEcCtD
Metoprolol—ABCB1—HIF-1-alpha transcription factor network—FOS—migraine	3.49e-05	0.00227	CbGpPWpGaD
Metoprolol—Dyspepsia—Gabapentin—migraine	3.47e-05	0.000428	CcSEcCtD
Metoprolol—Gastrointestinal pain—Timolol—migraine	3.46e-05	0.000427	CcSEcCtD
Metoprolol—Chest pain—Topiramate—migraine	3.46e-05	0.000426	CcSEcCtD
Metoprolol—Arthralgia—Topiramate—migraine	3.46e-05	0.000426	CcSEcCtD
Metoprolol—Anxiety—Topiramate—migraine	3.45e-05	0.000425	CcSEcCtD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	3.45e-05	0.00224	CbGpPWpGaD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	3.44e-05	0.000424	CcSEcCtD
Metoprolol—Asthenia—Valproic Acid—migraine	3.41e-05	0.000421	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Gabapentin—migraine	3.4e-05	0.00042	CcSEcCtD
Metoprolol—Fatigue—Gabapentin—migraine	3.4e-05	0.000419	CcSEcCtD
Metoprolol—Dry mouth—Topiramate—migraine	3.38e-05	0.000417	CcSEcCtD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	3.37e-05	0.00219	CbGpPWpGaD
Metoprolol—Pain—Gabapentin—migraine	3.37e-05	0.000416	CcSEcCtD
Metoprolol—Constipation—Gabapentin—migraine	3.37e-05	0.000416	CcSEcCtD
Metoprolol—Pruritus—Valproic Acid—migraine	3.36e-05	0.000415	CcSEcCtD
Metoprolol—Urticaria—Timolol—migraine	3.36e-05	0.000415	CcSEcCtD
Metoprolol—Abdominal pain—Timolol—migraine	3.35e-05	0.000413	CcSEcCtD
Metoprolol—Body temperature increased—Timolol—migraine	3.35e-05	0.000413	CcSEcCtD
Metoprolol—Confusional state—Topiramate—migraine	3.34e-05	0.000412	CcSEcCtD
Metoprolol—Oedema—Topiramate—migraine	3.32e-05	0.000409	CcSEcCtD
Metoprolol—Shock—Topiramate—migraine	3.26e-05	0.000402	CcSEcCtD
Metoprolol—Diarrhoea—Valproic Acid—migraine	3.25e-05	0.000401	CcSEcCtD
Metoprolol—Nervous system disorder—Topiramate—migraine	3.25e-05	0.000401	CcSEcCtD
Metoprolol—Feeling abnormal—Gabapentin—migraine	3.25e-05	0.0004	CcSEcCtD
Metoprolol—Thrombocytopenia—Topiramate—migraine	3.25e-05	0.0004	CcSEcCtD
Metoprolol—Tachycardia—Topiramate—migraine	3.24e-05	0.000399	CcSEcCtD
Metoprolol—Gastrointestinal pain—Gabapentin—migraine	3.22e-05	0.000397	CcSEcCtD
Metoprolol—ADRB1—GPCR ligand binding—HTR1B—migraine	3.22e-05	0.0021	CbGpPWpGaD
Metoprolol—Skin disorder—Topiramate—migraine	3.22e-05	0.000397	CcSEcCtD
Metoprolol—Hyperhidrosis—Topiramate—migraine	3.21e-05	0.000395	CcSEcCtD
Metoprolol—ADRB2—GPCR ligand binding—HTR1B—migraine	3.15e-05	0.00205	CbGpPWpGaD
Metoprolol—Dizziness—Valproic Acid—migraine	3.15e-05	0.000388	CcSEcCtD
Metoprolol—Urticaria—Gabapentin—migraine	3.13e-05	0.000386	CcSEcCtD
Metoprolol—Hypersensitivity—Timolol—migraine	3.12e-05	0.000384	CcSEcCtD
Metoprolol—Abdominal pain—Gabapentin—migraine	3.12e-05	0.000384	CcSEcCtD
Metoprolol—Body temperature increased—Gabapentin—migraine	3.12e-05	0.000384	CcSEcCtD
Metoprolol—ADRB1—GPCR ligand binding—HTR1A—migraine	3.1e-05	0.00202	CbGpPWpGaD
Metoprolol—Hypotension—Topiramate—migraine	3.1e-05	0.000382	CcSEcCtD
Metoprolol—ABCB1—Transmembrane transport of small molecules—ATP1A2—migraine	3.09e-05	0.00201	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—ATP1A3—migraine	3.09e-05	0.00201	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—NPS—migraine	3.06e-05	0.00199	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—TAC1—migraine	3.06e-05	0.00199	CbGpPWpGaD
Metoprolol—Asthenia—Timolol—migraine	3.04e-05	0.000374	CcSEcCtD
Metoprolol—ADRB2—GPCR ligand binding—HTR1A—migraine	3.04e-05	0.00197	CbGpPWpGaD
Metoprolol—Vomiting—Valproic Acid—migraine	3.02e-05	0.000373	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Topiramate—migraine	3.02e-05	0.000372	CcSEcCtD
Metoprolol—ADRB1—GPCR downstream signaling—HTR1D—migraine	3.01e-05	0.00196	CbGpPWpGaD
Metoprolol—Insomnia—Topiramate—migraine	3e-05	0.00037	CcSEcCtD
Metoprolol—Rash—Valproic Acid—migraine	3e-05	0.00037	CcSEcCtD
Metoprolol—ADRB1—GPCR ligand binding—HTR2C—migraine	3e-05	0.00195	CbGpPWpGaD
Metoprolol—Dermatitis—Valproic Acid—migraine	3e-05	0.000369	CcSEcCtD
Metoprolol—Pruritus—Timolol—migraine	3e-05	0.000369	CcSEcCtD
Metoprolol—ADRB2—GPCR ligand binding—NPS—migraine	2.99e-05	0.00194	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—TAC1—migraine	2.99e-05	0.00194	CbGpPWpGaD
Metoprolol—Headache—Valproic Acid—migraine	2.98e-05	0.000367	CcSEcCtD
Metoprolol—Paraesthesia—Topiramate—migraine	2.98e-05	0.000367	CcSEcCtD
Metoprolol—Dyspnoea—Topiramate—migraine	2.96e-05	0.000364	CcSEcCtD
Metoprolol—Somnolence—Topiramate—migraine	2.95e-05	0.000363	CcSEcCtD
Metoprolol—ADRB2—GPCR downstream signaling—HTR1D—migraine	2.94e-05	0.00191	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—HTR2C—migraine	2.93e-05	0.00191	CbGpPWpGaD
Metoprolol—Dyspepsia—Topiramate—migraine	2.92e-05	0.00036	CcSEcCtD
Metoprolol—ADRB1—GPCR ligand binding—EDNRA—migraine	2.92e-05	0.0019	CbGpPWpGaD
Metoprolol—Hypersensitivity—Gabapentin—migraine	2.9e-05	0.000358	CcSEcCtD
Metoprolol—Diarrhoea—Timolol—migraine	2.9e-05	0.000357	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Topiramate—migraine	2.86e-05	0.000353	CcSEcCtD
Metoprolol—Fatigue—Topiramate—migraine	2.86e-05	0.000352	CcSEcCtD
Metoprolol—ADRB2—GPCR ligand binding—EDNRA—migraine	2.85e-05	0.00185	CbGpPWpGaD
Metoprolol—Constipation—Topiramate—migraine	2.84e-05	0.00035	CcSEcCtD
Metoprolol—Pain—Topiramate—migraine	2.84e-05	0.00035	CcSEcCtD
Metoprolol—Asthenia—Gabapentin—migraine	2.83e-05	0.000349	CcSEcCtD
Metoprolol—Nausea—Valproic Acid—migraine	2.83e-05	0.000348	CcSEcCtD
Metoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	2.82e-05	0.00183	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—CALCA—migraine	2.81e-05	0.00183	CbGpPWpGaD
Metoprolol—Dizziness—Timolol—migraine	2.8e-05	0.000345	CcSEcCtD
Metoprolol—ADRB1—GPCR downstream signaling—HTR2B—migraine	2.8e-05	0.00182	CbGpPWpGaD
Metoprolol—Pruritus—Gabapentin—migraine	2.79e-05	0.000344	CcSEcCtD
Metoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	2.76e-05	0.00179	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—CALCA—migraine	2.75e-05	0.00179	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—HTR2B—migraine	2.73e-05	0.00178	CbGpPWpGaD
Metoprolol—Feeling abnormal—Topiramate—migraine	2.73e-05	0.000337	CcSEcCtD
Metoprolol—ADRB1—Signaling by GPCR—HTR1D—migraine	2.73e-05	0.00178	CbGpPWpGaD
Metoprolol—Gastrointestinal pain—Topiramate—migraine	2.71e-05	0.000334	CcSEcCtD
Metoprolol—Diarrhoea—Gabapentin—migraine	2.7e-05	0.000332	CcSEcCtD
Metoprolol—Vomiting—Timolol—migraine	2.69e-05	0.000332	CcSEcCtD
Metoprolol—ADRB2—Signaling by GPCR—HTR1D—migraine	2.67e-05	0.00174	CbGpPWpGaD
Metoprolol—Rash—Timolol—migraine	2.67e-05	0.000329	CcSEcCtD
Metoprolol—Dermatitis—Timolol—migraine	2.67e-05	0.000329	CcSEcCtD
Metoprolol—Headache—Timolol—migraine	2.65e-05	0.000327	CcSEcCtD
Metoprolol—Urticaria—Topiramate—migraine	2.64e-05	0.000325	CcSEcCtD
Metoprolol—ABCB1—Transmembrane transport of small molecules—HTR3A—migraine	2.63e-05	0.00171	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—HTR7—migraine	2.63e-05	0.00171	CbGpPWpGaD
Metoprolol—Abdominal pain—Topiramate—migraine	2.62e-05	0.000323	CcSEcCtD
Metoprolol—Body temperature increased—Topiramate—migraine	2.62e-05	0.000323	CcSEcCtD
Metoprolol—Dizziness—Gabapentin—migraine	2.61e-05	0.000321	CcSEcCtD
Metoprolol—ADRB2—GPCR ligand binding—HTR7—migraine	2.57e-05	0.00167	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—HTR2B—migraine	2.54e-05	0.00165	CbGpPWpGaD
Metoprolol—Nausea—Timolol—migraine	2.51e-05	0.00031	CcSEcCtD
Metoprolol—Vomiting—Gabapentin—migraine	2.51e-05	0.000309	CcSEcCtD
Metoprolol—Rash—Gabapentin—migraine	2.49e-05	0.000306	CcSEcCtD
Metoprolol—Dermatitis—Gabapentin—migraine	2.48e-05	0.000306	CcSEcCtD
Metoprolol—ADRB2—Signaling by GPCR—HTR2B—migraine	2.48e-05	0.00162	CbGpPWpGaD
Metoprolol—Headache—Gabapentin—migraine	2.47e-05	0.000304	CcSEcCtD
Metoprolol—Hypersensitivity—Topiramate—migraine	2.44e-05	0.000301	CcSEcCtD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	2.41e-05	0.00157	CbGpPWpGaD
Metoprolol—Asthenia—Topiramate—migraine	2.38e-05	0.000293	CcSEcCtD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	2.36e-05	0.00154	CbGpPWpGaD
Metoprolol—Pruritus—Topiramate—migraine	2.35e-05	0.000289	CcSEcCtD
Metoprolol—Nausea—Gabapentin—migraine	2.34e-05	0.000289	CcSEcCtD
Metoprolol—Diarrhoea—Topiramate—migraine	2.27e-05	0.00028	CcSEcCtD
Metoprolol—ADRB1—Signaling Pathways—RAMP1—migraine	2.22e-05	0.00144	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CALCRL—migraine	2.22e-05	0.00144	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—migraine	2.21e-05	0.00143	CbGpPWpGaD
Metoprolol—Dizziness—Topiramate—migraine	2.19e-05	0.00027	CcSEcCtD
Metoprolol—ADRB2—Signaling Pathways—CALCRL—migraine	2.17e-05	0.00141	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—RAMP1—migraine	2.17e-05	0.00141	CbGpPWpGaD
Metoprolol—Vomiting—Topiramate—migraine	2.11e-05	0.00026	CcSEcCtD
Metoprolol—Rash—Topiramate—migraine	2.09e-05	0.000258	CcSEcCtD
Metoprolol—Dermatitis—Topiramate—migraine	2.09e-05	0.000258	CcSEcCtD
Metoprolol—Headache—Topiramate—migraine	2.08e-05	0.000256	CcSEcCtD
Metoprolol—Nausea—Topiramate—migraine	1.97e-05	0.000243	CcSEcCtD
Metoprolol—SLC22A2—Metabolism—CACNA1A—migraine	1.91e-05	0.00125	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—HTR2A—migraine	1.84e-05	0.0012	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—HTR1B—migraine	1.82e-05	0.00118	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—HTR2A—migraine	1.8e-05	0.00117	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—HTR1B—migraine	1.78e-05	0.00116	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—HTR1A—migraine	1.75e-05	0.00114	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—TAC1—migraine	1.73e-05	0.00112	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—NPS—migraine	1.73e-05	0.00112	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—HTR1A—migraine	1.72e-05	0.00112	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—HTR2C—migraine	1.69e-05	0.0011	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—TAC1—migraine	1.69e-05	0.0011	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—NPS—migraine	1.69e-05	0.0011	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—HTR2C—migraine	1.66e-05	0.00108	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—HTR1B—migraine	1.65e-05	0.00108	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—migraine	1.65e-05	0.00108	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—EDNRA—migraine	1.65e-05	0.00107	CbGpPWpGaD
Metoprolol—ABCB1—Allograft Rejection—TNF—migraine	1.62e-05	0.00106	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—HTR1B—migraine	1.62e-05	0.00105	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—HTR1D—migraine	1.61e-05	0.00105	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—EDNRA—migraine	1.61e-05	0.00105	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—HTR1A—migraine	1.59e-05	0.00104	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—CALCA—migraine	1.59e-05	0.00103	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—HTR1D—migraine	1.58e-05	0.00103	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—TAC1—migraine	1.57e-05	0.00102	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—NPS—migraine	1.57e-05	0.00102	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—HTR1A—migraine	1.56e-05	0.00101	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—CALCA—migraine	1.55e-05	0.00101	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—HTR2C—migraine	1.54e-05	0.001	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—NPS—migraine	1.53e-05	0.000998	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—TAC1—migraine	1.53e-05	0.000998	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—HTR2C—migraine	1.5e-05	0.000979	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—HTR2B—migraine	1.5e-05	0.000975	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—EDNRA—migraine	1.5e-05	0.000973	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—HTR7—migraine	1.48e-05	0.000965	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—HTR2B—migraine	1.47e-05	0.000954	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—EDNRA—migraine	1.46e-05	0.000952	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—HTR7—migraine	1.45e-05	0.000944	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—CALCA—migraine	1.44e-05	0.000937	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—CALCA—migraine	1.41e-05	0.000916	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—HTR7—migraine	1.35e-05	0.000876	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—LRP1—migraine	1.32e-05	0.000859	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—HTR7—migraine	1.32e-05	0.000857	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—LRP1—migraine	1.29e-05	0.00084	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CACNA1A—migraine	1.07e-05	0.000697	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CACNA1A—migraine	1.05e-05	0.00068	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—HTR2A—migraine	1.04e-05	0.000676	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—HTR2A—migraine	1.02e-05	0.000661	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—NOTCH4—migraine	1.01e-05	0.000659	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—NOTCH4—migraine	9.91e-06	0.000644	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CACNA1A—migraine	9.86e-06	0.000641	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—HTR1B—migraine	9.77e-06	0.000636	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—HTR1B—migraine	9.56e-06	0.000622	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—HTR2A—migraine	9.44e-06	0.000614	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—HTR1A—migraine	9.41e-06	0.000612	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PGR—migraine	9.26e-06	0.000603	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—TAC1—migraine	9.26e-06	0.000603	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—NPS—migraine	9.26e-06	0.000603	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—HTR2A—migraine	9.23e-06	0.0006	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—HTR1A—migraine	9.2e-06	0.000599	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—HTR2C—migraine	9.09e-06	0.000591	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—NPS—migraine	9.06e-06	0.000589	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PGR—migraine	9.06e-06	0.000589	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—TAC1—migraine	9.06e-06	0.000589	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—HTR2C—migraine	8.89e-06	0.000578	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—EDNRA—migraine	8.84e-06	0.000575	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—EDNRA—migraine	8.65e-06	0.000562	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—NOTCH3—migraine	8.61e-06	0.00056	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CALCA—migraine	8.51e-06	0.000553	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—NOTCH3—migraine	8.43e-06	0.000548	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CALCA—migraine	8.32e-06	0.000541	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—migraine	8.01e-06	0.000521	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—HTR7—migraine	7.96e-06	0.000518	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—HTR7—migraine	7.78e-06	0.000506	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—TGFBR2—migraine	6.85e-06	0.000446	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—TGFBR2—migraine	6.7e-06	0.000436	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—MTHFR—migraine	6.33e-06	0.000412	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—HTR2A—migraine	5.57e-06	0.000363	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—HTR2A—migraine	5.45e-06	0.000355	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—ESR1—migraine	4.95e-06	0.000322	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—ESR1—migraine	4.84e-06	0.000315	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—MTHFR—migraine	3.55e-06	0.000231	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—MTHFR—migraine	3.46e-06	0.000225	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—MTHFR—migraine	3.26e-06	0.000212	CbGpPWpGaD
